NO responsiveness in pulmonary artery and airway smooth muscle: The role of cGMP regulation

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 290, Issue 1, 2006, Pages

  Kwak, Young L ^b   Jones, Keith A ^a   Warner, David O ^a   Perkins, William J ^a  

^a MAYO CLINIC   (United States)

^b Yonsei University   (South Korea)

Author keywords

Airway smooth muscle; Guanosine 3 ,5 cyclic monophosphate; Molecular sequence data; Nitric oxide; Phosphodiesterase; Pulmonary artery; Soluble guanylate cyclase

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; ACETYLCHOLINE; CYCLIC GMP; ISOBUTYLMETHYLXANTHINE; NITRIC OXIDE; PHENYLEPHRINE; PHOSPHODIESTERASE; POTASSIUM CHLORIDE; 1-HYDROXY-2-OXO-3,3-BIS(2-AMINOETHYL)-1-TRIAZENE; CELL RECEPTOR; GUANYLATE CYCLASE; ISOENZYME; MESSENGER RNA; NITRIC OXIDE DONOR; SOLUBLE GUANYLYL CYCLASE; TRIAZENE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; DOG; ENZYME INHIBITION; MOLECULAR GENETICS; MUSCLE CONTRACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; SMOOTH MUSCLE; TRACHEA; ANIMAL; DOSE RESPONSE; DRUG EFFECT; FEMALE; GENETICS; HUMAN; IN VITRO STUDY; MALE; METABOLISM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; CYCLIC GMP; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUANYLATE CYCLASE; HUMANS; ISOENZYMES; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE DONORS; PHOSPHORIC DIESTER HYDROLASES; PULMONARY ARTERY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRACHEA; TRIAZENES; VASOCONSTRICTION;

EID: 33644807691     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00186.2005     Document Type: Article

References (50)

1. Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, and Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 91: 7583-7587, 1994.
2. Becker-Andre M and Hahlbrock K. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res 17: 9437-9446, 1989.
3. Bellamy TC, Wood J, Goodwin DA, and Garthwaite J. Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc Natl Acad Sci USA 97: 2928-2933, 2000.
4. Black SM, Sanchez LS, Mata-Greenwood E, Bekker JM, Steinhorn RH, and Fineman JR. sGC and PDE5 are elevated in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 281: L1051-L1057, 2001.
5. Buechler WA, Nakane M, and Murad F. Expression of soluble guanylate cyclase activity requires both enzyme subunits. Biochem Biophys Res Commun 174: 351-357, 1991.
6. Buga GM, Gold ME, Wood KS, Chaudhuri G, and Ignarro LJ. Endothelium-derived nitric oxide relaxes nonvascular smooth muscle. Eur J Pharmacol 161: 61-72, 1989.
7. Carter TD, Bettache N, and Ogden D. Potency and kinetics of nitric oxide-mediated vascular smooth muscle relaxation determined with flash photolysis of ruthenium nitrosyl chlorides. Br J Pharmacol 122: 971-973, 1997.
8. Chirgwin JM, Przybyla AE, MacDonald RJ, and Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979.
9. Dhanakoti SN, Gao Y, Nguyen MQ, and Raj JU. Involvement of cGMP-dependent protein kinase in the relaxation of ovine pulmonary arteries to cGMP and cAMP. J Appl Physiol 88: 1637-1642, 2000.
10. Felbel J, Trockur B, Ecker T, Landgraf W, and Hofmann F. Regulation of cytosolic calcium by cAMP and cGMP in freshly isolated smooth muscle cells from bovine trachea. J Biol Chem 263: 16764-16771, 1988.
11. Filippov G, Bloch DB, and Bloch KD. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J Clin Invest 100: 942-948, 1997.
12. Gao Y, Dhanakoti S, Tolsa JF, and Raj JU. Role of protein kinase G in nitric oxide- and cGMP-induced relaxation of newborn ovine pulmonary veins. J Appl Physiol 87: 993-998, 1999.
13. Geiselhoringer A, Werner M, Sigl K, Smital P, Worner R, Acheo L, Stieber J, Weinmeister P, Feil R, Feil S, Wegener J, Hofmann F, and Schlossmann J. IRAG is essential for relaxation of receptor-triggered smooth muscle contraction by cGMP kinase. EMBO J 23: 4222-4231, 2004.
14. Gibb BJ, Wykes V, and Garthwaite J. Properties of NO-activated guanylyl cyclases expressed in cells. Br J Pharmacol 139: 1032-1040, 2003.
15. Giembycz MA and Raeburn D. Putative substrates for cyclic nucleotide-dependent protein kinases and the control of airway smooth muscle tone. J Auton Pharmacol 11: 365-398, 1991.
16. Gilliland G, Perrin S, Blanchard K, and Bunn HF. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 87: 2725-2729, 1990.
17. Giuili G, Scholl U, Bulle F, and Guellaen G. Molecular cloning of the cDNAs coding for the two subunits of soluble guanylyl cyclase from human brain. FEBS Lett 304: 83-88, 1992.
18. Hobbs AJ and Ignarro LJ. Nitric oxide-cyclic GMP signal transduction system. Methods Enzymol 269: 134-148, 1996.
19. Hogman M, Frostell CG, Hedenstrom H, and Hedenstierna G. Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis 148: 1474-1478, 1993.
20. 2+ in airway smooth muscle independently of cyclic nucleotides. Am J Physiol Lung Cell Mol Physiol 268: L166-L172, 1995.
21. Kacmarek RM, Ripple R, Cockrill BA, Bloch KJ, Zapol WM, and Johnson DC. Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am J Respir Crit Care Med 153: 128-135, 1996.
22. Keefer LK. Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates. Annu Rev Pharmacol Toxicol 43: 585-607, 2003.
23. Keefer LK, Nims RW, Davies KM, and Wink DA. "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol 268: 281-293, 1996.
24. Kennedy T, Summer WR, Sylvester J, and Robertson D. Airway response to sublingual nitroglycerin in acute asthma. JAMA 246: 145-147, 1981.
25. Kloss S, Furneaux H, and Mulsch A. Post-transcriptional regulation of soluble guanylyl cyclase expression in rat aorta. J Biol Chem 278: 2377-2383, 2003.
26. Koglin M, Vehse K, Budaeus L, Scholz H, and Behrends S. Nitric oxide activates the beta 2 subunit of soluble guanylyl cyclase in the absence of a second subunit. J Biol Chem 276: 30737-30743., 2001.
27. Kreye VA and Marquard E. Comparison of sodium nitroprusside and isoprenaline aerosols in histamine-induced bronchial asthma of the guinea pig. Naunyn Schmiedebergs Arch Pharmacol 306: 203-207, 1979.
28. Lowry AH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the Folin reagent. J Biol Chem 193: 265-275, 1951.
29. Maclean MR, Johnston ED, McCulloch KM, Pooley L, Houslay MD, and Sweeney G. Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension. J Pharmacol Exp Ther 283: 619-624., 1997.
30. Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Isaac L, Hrabie JA, and Keefer LK. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 34: 3242-3247, 1991.
31. Meddings JB, Scott RB, and Fick GH. Analysis and comparison of sigmoidal curves: application to dose-response data. Am J Physiol Gastrointest Liver Physiol 257: G982-G989, 1989.
32. Moro MA, Russell RJ, Cellek S, Lizasoain I, Su YC, Darleyusmar VM, Radomski MW, and Moncada S. cGMP mediates the vascular and platelet actions of nitric oxide - confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci USA 93: 1480-1485, 1996.
33. Murad F. Regulation of cytosolic guanylyl cyclase by nitric oxide: The NO-cyclic GMP signal transduction system. In: Cyclic GMP: Synthesis, Metabolism, and Function, edited by Murad F. San Diego, CA: Academic, 1994, p. 19-33.
34. Nakane M, Arai K, Saheki S, Kuno T, Buechler W, and Murad F. Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J Biol Chem 265: 16841-16845, 1990.
35. Nedvetsky PI, Kleinschnitz C, and Schmidt HH. Regional distribution of protein and activity of the nitric oxide receptor, soluble guanylyl cyclase, in rat brain suggests multiple mechanisms of regulation. Brain Res 950: 148-154, 2002.
36. Nishikawa M, de Lanerolle P, Lincoln TM, and Adelstein RS. Phosphorylation of mammalian myosin light chain kinases by the catalytic subunit of cyclic AMP-dependent protein kinase and by cyclic GMP-dependent protein kinase. J Biol Chem 259: 8429-8436, 1984.
37. Pabelick CM, Warner DO, Perkins WJ, and Jones KA. S-nitrosoglutathione- induced decrease in calcium sensitivity of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 278: L521-L527, 2000.
38. Pauvert O, Salvail D, Rousseau E, Lugnier C, Marthan R, and Savineau JP. Characterisation of cyclic nucleotide phosphodiesterase isoforms in the media layer of the main pulmonary artery. Biochem Pharmacol 63: 1763-1772, 2002.
39. Perkins WJ, Pabelick C, Warner DO, and Jones KA. cGMP-independent mechanism of airway smooth muscle relaxation induced by S-nitrosoglutathione. Am J Physiol Cell Physiol 275: C468-C474, 1998.
40. 2+ sensitivity in airway smooth muscle. J Appl Physiol 92: 257-263, 2002.
41. Sanger F, Nicklen S, and Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467, 1977.
42. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
43. Stuart-Smith K, Bynoe TC, Lindeman KS, and Hirshman CA. Differential effects of nitrovasodilators and nitric oxide on porcine tracheal and bronchial muscle in vitro. J Appl Physiol 77: 1142-1147, 1994.
44. Torphy TJ, Undem BJ, Cieslinski LB, Luttmann MA, Reeves ML, and Hay DW. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J Pharmacol Exp Ther 265: 1213-1223, 1993.
45. - currents by NO donors in cat tracheal smooth muscle. J Physiol 511: 719-731, 1998.
46. Wedel B, Humbert P, Harteneck C, Foerster J, Malkewitz J, Bohme E, Schultz G, and Koesling D. Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proc Natl Acad Sci USA 91: 2592-2596, 1994.
47. Wernet W, Flockerzi V, and Hofmann F. The cDNA of the two isoforms of bovine cGMP-dependent protein kinase. FEBS Lett 251: 191-196, 1989.
48. Zabel U, Hausler C, Weeger M, and Schmidt HH. Homodimerization of soluble guanylyl cyclase subunits. Dimerization analysis using a glutathione s-transferase affinity tag. J Biol Chem 274: 18149-18152, 1999.
49. Zabel U, Weeger M, La M, and Schmidt HH. Human soluble guanylate cyclase: functional expression and revised isoenzyme family. Biochem J 335: 51-57, 1998.
50. Zhou HL and Torphy TJ. Relationship between cyclic guanosine monophosphate accumulation and relaxation of canine trachealis induced by nitrovasodilators. J Pharmacol Exp Ther 258: 972-978, 1991.